News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
State-of-the-art biomimetic tissue engineered technologies for cancer research
Aug 21, 2024, 19:50

State-of-the-art biomimetic tissue engineered technologies for cancer research

NCI Physical Sciences shared a post on X:

“The Cancer Tissue Engineering Collaborative Program of National Cancer Institute supports the development and characterization of state-of-the-art biomimetic tissue engineered technologies for cancer research.”

State-of-the-art biomimetic tissue engineered technologies for cancer research

Source: NCI Physical Sciences/X

cancer National Cancer Institute NCI Physical Sciences OncoDaily Oncology
Insight
Aug 21, 2024, 19:50
State-of-the-art biomimetic tissue engineered technologies for cancer research
Insight
Aug 21, 2024, 19:46
Characterizing Tumor-Immune interactions in Lung Cancer Development
Blog
Aug 21, 2024, 19:41
Bishal Gyawali: 2 most important tables you'll need for VTE prophylaxis and treatment with DOACs
Blog
Aug 21, 2024, 17:42
Francisco J. Esteva: Where in the world are the largest gaps in female specific cancers?
Insight
Aug 21, 2024, 17:41
Judy Tung: Leadership that impacts well-being can be taught
Blog
Aug 21, 2024, 17:36
Zainab Shinkafi-Bagudu: Medicaid Cancer Foundation and BISON collaborate to expand Breast cancer detection
Blog
Aug 21, 2024, 17:28
Douglas Flora: The Great Wave off Kanagawa captures my feelings on certain days
Blog
Aug 21, 2024, 17:22
Join CancerX Moonshot to learn about Advancing Equity and Reducing Financial Toxicity in Cancer Care
Blog
Aug 21, 2024, 17:18
Dean Crowe: You will be impressed if you get a chance to tour the new Arthur M. Blank Children's Hospital
Blog
Aug 21, 2024, 17:15
Cancer and HIV stigma - conference by The NCI Division of Cancer Control and Population Sciences
Blog
Aug 21, 2024, 17:11
Hil Moss: Great chance to share about what we are building and why at Oncovery
Insight
Aug 21, 2024, 17:08
What oncologists say about the new approval of Lazertinib and amivantamab for advanced NSCLC